TScan Therapeutics
TCRX
TCRX
89 hedge funds and large institutions have $208M invested in TScan Therapeutics in 2024 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 26 increasing their positions, 17 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
0.6% more ownership
Funds ownership: 85.31% → 85.9% (+0.6%)
14% less capital invested
Capital invested by funds: $242M → $208M (-$34.1M)
Holders
89
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$4.11M | |
| 2 | +$1.13M | |
| 3 | +$1.06M | |
| 4 |
BlackRock
New York
|
+$849K |
| 5 |
State Street
Boston,
Massachusetts
|
+$739K |
Top Sellers
| 1 | -$2.96M | |
| 2 | -$2.4M | |
| 3 | -$2.07M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$924K |
| 5 |
AGM
Alpine Global Management
New York
|
-$804K |